Merck Says Ebola Vaccine to Be Available at Lowest Access Price for Poor Nations Merck Says Ebola Vaccine to Be Available at Lowest Access Price for Poor Nations

Merck& Co said on Friday it expects to make licensed doses of its recently approved Ebola vaccine available in the third quarter of 2020 and price the single-dose injection at the lowest possible access price for poor and middle-income countries.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Public Health & Prevention News Source Type: news